Trial · NCT04042857
Safety and Efficacy of Next Science Gel on Toenail Fungus
NCT04042857, Not applicable, Recruiting, Next Science TM
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Safety and Efficacy of Next Science Gel on Toenail Fungus. Trials, record NCT04042857. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04042857
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Safety and Efficacy of Next Science Gel on Toenail Fungus
- NCT number
- NCT04042857
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 20 participants, estimated
- Lead sponsor
- Next Science TM
- Conditions
- Onychomycosis of Toenail
- Interventions
- Next Science Treatment Gel
- First posted
- 2019-08-02
- Last updated
- 2019-08-02
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mycological Cure at 48 Weeks | Baseline to 48 Weeks | Mycological cure rate at week 48 as defined by negative potassium hydroxide examination and negative culture of the target hallux nail |
| Primary | Clinical Efficacy at 48 Weeks | Baseline to 48 Weeks | Clinical efficacy rate at week 48 as defined by less than 10% clinical involvement of the target hallux nail |
| Secondary | Complete Cure at Week 48 | Baseline to 48 Weeks | Complete cure rate at week 48 defined as 0% clinical involvement, negative potassium hydroxide examination and negative culture of the target hallux nail |
| Secondary | Complete Cure at Week 52 | Baseline to 52 Weeks | Complete cure rate at week 52 defined as 0% clinical involvement, negative mycology, and negative potassium hydroxide examination of the target hallux nail at week 52 |
| Secondary | Almost Complete Cure at Week 48 | Baseline to 48 Weeks | Almost complete cure rate at week 48 defined as less than 10% clinical involvement, negative potassium hydroxide examination, and negative culture of the target hallux nail at week 48 |
| Secondary | Almost Complete Cure at Week 52 | Baseline to Week 52 | Almost complete cure rate at week 52 defined as less than 10% clinical involvement, negative potassium hydroxide examination, and negative culture of the target hallux nail at Week 52 |
| Secondary | Time to Complete Cure | Baseline to 52 Weeks | Measured across all observation points |
| Secondary | Time to Almost Complete Cure | Baseline to 52 Weeks | Measured across all observation points |
| Secondary | Percent Change in Area of Nail Involvement | Baseline to 52 Weeks | Calculated as a ratio of clear to involved measured across all observation points |
| Secondary | Growth of Clear Nail | Baseline to 52 Weeks | Change in area of clear nail growth measured across all observation points |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04042857
GET https://conductscience.org/api/trials/v1/NCT04042857/registered